Company Overview and News

to your dashboard

Headline News

An 'All-Weather' Income Portfolio For Financial Independence

2018-01-21 seekingalpha
Over the past year I have set out to turn profits from the aging bull market into a stable, incoming-producing portfolio for financial independence. (129-2)

Illumina's (ILMN) Q4 Earnings to Show Growth in All Lines

2018-01-19 zacks
Illumina, Inc. (ILMN - Free Report) is slated to report fourth-quarter fiscal 2017 results on Jan 30, after market close. Last quarter, the company delivered a positive earnings surprise of 13.3%. Let's see how things are shaping up ahead of this announcement. (19-0)

Healthcare: The 'Week That Was' Was Good

2018-01-17 seekingalpha
Last month, I  explained my rationale for expecting favorable performance from healthcare stocks in January. In biopharmaceuticals, I highlighted Juno Therapeutics, bluebird bio, Madrigal, Arbutus, Conatus  and DURECT, among others. (151-0)

Illumina: Great Company, Expensive Stock

2018-01-17 seekingalpha
In my view, the market is assuming Illumina will grow at an astonishing rate in perpetuity. (2-0)

Canaccord Genuity Issues Top 5 Diagnostics Picks for 2018

2018-01-16 247wallst
It’s a new year, and the bull market has raged on after the Dow rose 25% and the S&P 500 rose over 19% last year. 24/7 Wall St. has tracked many analyst calls sending their price targets higher and higher in the new year, and even our own initial target price of 26,400 on the Dow (and 2,855 on the S&P 500) now look like absolute baseline numbers rather than annual targets for real upside after what this year’s gains feel like. (9-0)

4 ETFs Set to Surge in Q4 Earnings

2018-01-15 zacks
The fourth-quarter earnings season is expected to be strong, with earnings growth likely to pick up and continue accelerating after dipping in the preceding quarter. The S&P 500 index is anticipated to see earnings growth of 9.2% and revenue growth of 7%. The market is also at record levels, scaling series of highs at the start of the year. The forecast compares favorably with Q3 earnings growth of 6. (190-1)

Illumina (ILMN) Ties Up With Thermo Fisher for Ion AmpliSeq

2018-01-15 zacks
Illumina, Inc. (ILMN - Free Report) has signed a commercial agreement to distribute Thermo Fisher Scientific Inc.’s (TMO - Free Report) Ion AmpliSeq technology to researchers who conduct studies on Illumina’s next-generation sequencing (NGS) platform. (36-0)

Sheryl Sandberg, Jack Dorsey to Leave Disney’s Board - Bloomberg

2018-01-13 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (245-2)

BRIEF-Illumina Sees Non-GAAP Diluted EPS Attributable To Illumina Stockholders In Range Of $4.50-$4.60 For Fiscal Year 2018

2018-01-11 reuters

Pacific Biosciences Hurt by Competition in Niche Markets

2018-01-10 zacks
On Jan 9, we issued an updated research report on Pacific Biosciences of California Inc. (PACB - Free Report) . Solid contribution from the Instrument and Consumable revenue platforms have been boosting Pacific Biosciences' growth trajectory. However, cutthroat competition in the niche space has been hampering Pacific Biosciences revenues. The stock has a Zacks Rank #4 (Sell). (20-0)

Illumina (ILMN) Looks Good: Stock Adds 6.9% in Session

2018-01-10 zacks
Illumina, Inc. (ILMN - Free Report) was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $210.85 to $232.99 in the past one-month time frame. The move came after the company announced the latest gene-sequencing machine as well as issued earnings guidance for 2018 that outpaced the analysts' projections. (3-0)

PacBio's Library Preparation Issues Announced At A Tough Time

2018-01-09 seekingalpha
Correcting this issue may cause short term stress and will test the company's ability to respond to difficult situations. (4-1)

Week In Review: China Life Science Starts 2018 With $2 Billion Week

2018-01-07 seekingalpha
Perennial Real Estate Holdings (SGX: 40S), a Singapore company, announced a $1.2 billion joint venture that will acquire and develop healthcare centers in China. It plans to concentrate on integrated mixed-use developments, centered around healthcare, that are connected to China high speed railway stations. Perennial is already building two such properties, one in Chengdu and the other in Xi'an. Its major partner in the JV will be Shun Tak Holdings (HK: 242), a Hong Kong conglomerate. (253-1)

How To Offer More Value To Your Clients In 2018

2018-01-02 seekingalpha
If you're putting your clients' assets in low-cost index funds, why are they paying you for investing advice? That kind of advice is offered free online. (403-0)

And the S&P’s Biggest Winner This Year Is... A Dental Company - Bloomberg

2017-12-29 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (308-1)

CUSIP: 452327109